-
Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds
Post on 10/28/19
-
Athene and Apollo Announce Transaction to Strengthen Strategic Relationship
Post on 10/28/19
-
BASF and Greentown Labs Announce Startup Finalists in the Circularity Challenge
Post on 10/28/19
-
Better Buy: Pfizer vs. Merck
Post on 10/28/19
-
Better Buy: Vertex Pharmaceuticals vs. Incyte
Post on 10/28/19
-
iBio Prices $5M Public Offering
Post on 10/25/19
-
Tri-State Hospital Group Partners to Improve Healthcare Quality, Patient Safety
Post on 10/24/19
-
Advaxis Announces Business and Pipeline Update
Post on 10/24/19
-
Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
Post on 10/24/19
-
Athenex Provides An Update to Shareholders
Post on 10/24/19
-
Integra LifeSciences Reports Third Quarter 2019 Financial Results
Post on 10/24/19
-
Acorda Therapeutics Implements Corporate Restructuring
Post on 10/23/19
-
BioAegis Therapeutics Named New Jersey’s Most Valuable Venture-Backed Company Led by a Woman
Post on 10/23/19
-
Colangelo Adds Vireo Health to Client Roster
Post on 10/23/19
-
Progenics To Be Acquired By Lantheus Holdings: Deciding To Buy, Sell, Or Hold
Post on 10/23/19
-
Onegevity Health Acquires Global Licensing Rights to Mount Sinai's Lab100
Post on 10/22/19
-
Quest Diagnostics Reports Third Quarter 2019 Financial Results
Post on 10/22/19
-
Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities
Post on 10/22/19
-
Why I Added More Johnson & Johnson During Friday's Overreactive Dip
Post on 10/22/19
-
IPO Update: Oyster Point Pharma Readies $85 Million IPO
Post on 10/22/19
-
Johnson & Johnson: Yield Still Not Worth The Legal Risk
Post on 10/22/19
-
Pfizer: Avoid This High Yield
Post on 10/22/19
-
HealthEC, LabCorp, and The New Jersey Primary Care Association Announce Strategic Collaboration
Post on 10/21/19
-
Why Johnson & Johnson Stock Sank Today
Post on 10/21/19
-
Better Buy: Geron vs. Celgene
Post on 10/21/19